Literature DB >> 29167185

Hyperacute leucopenia associated with furosemide.

Ben-Jiang Ma1,2.   

Abstract

A 72-year-old man presented to the hospital with exacerbation of congestive heart failure. He was given furosemide 40 mg intravenously twice at 4 hours apart. At 4 hours after the second dose of furosemide, his white blood cells (WBC) dropped acutely from 9.8 to 2.4×109/L (reference range 4.1 to 9.3×109/L). With the discontinuation of furosemide, the WBC trended up to 7.1×109/L about 13 hours after the second dose of intravenous furosemide and remained in normal range for the next 3 days. However, when the oral furosemide was started on hospital day 4, there was a mild drop in WBC count, which returned to and maintained at baseline since the next day. The dynamic changes in the patient's WBC were coincident with the use of furosemide. The possible mechanisms of furosemide-associated transient hyperacute leucopenia were discussed. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  cardiovascular system; haematology (drugs and medicines)

Mesh:

Substances:

Year:  2017        PMID: 29167185      PMCID: PMC5720266          DOI: 10.1136/bcr-2016-218776

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Potentiators and bolus intravenous furosemide.

Authors:  D J Cook; C F Tudball
Journal:  Lancet       Date:  2001-10-20       Impact factor: 79.321

Review 2.  Loop diuretics: from the Na-K-2Cl transporter to clinical use.

Authors:  Sudha S Shankar; D Craig Brater
Journal:  Am J Physiol Renal Physiol       Date:  2003-01

Review 3.  Approach to managing patients with sulfa allergy: use of antibiotic and nonantibiotic sulfonamides.

Authors:  David Ponka
Journal:  Can Fam Physician       Date:  2006-11       Impact factor: 3.275

4.  Case report: furosemide and pancreatitis: Importance of dose and latency period before reaction.

Authors:  Chia-Ter Chao; Jia-Yu Chao
Journal:  Can Fam Physician       Date:  2013-01       Impact factor: 3.275

5.  Thrombocytopenia due to sulfonamide cross-sensitivity.

Authors:  J A Bretza
Journal:  Wis Med J       Date:  1982-06

6.  Diuretic strategies in patients with acute decompensated heart failure.

Authors:  G Michael Felker; Kerry L Lee; David A Bull; Margaret M Redfield; Lynne W Stevenson; Steven R Goldsmith; Martin M LeWinter; Anita Deswal; Jean L Rouleau; Elizabeth O Ofili; Kevin J Anstrom; Adrian F Hernandez; Steven E McNulty; Eric J Velazquez; Abdallah G Kfoury; Horng H Chen; Michael M Givertz; Marc J Semigran; Bradley A Bart; Alice M Mascette; Eugene Braunwald; Christopher M O'Connor
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

7.  Probable loop diuretic-induced pancreatitis in a sulfonamide-allergic patient.

Authors:  Paul Juang; Robert L Page; Ronald Zolty
Journal:  Ann Pharmacother       Date:  2005-12-13       Impact factor: 3.154

8.  Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics.

Authors:  Brian L Strom; Rita Schinnar; Andrea J Apter; David J Margolis; Ebbing Lautenbach; Sean Hennessy; Warren B Bilker; Dan Pettitt
Journal:  N Engl J Med       Date:  2003-10-23       Impact factor: 91.245

Review 9.  Likelihood and mechanisms of cross-allergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group.

Authors:  Carolyn C Brackett; Harleen Singh; John H Block
Journal:  Pharmacotherapy       Date:  2004-07       Impact factor: 4.705

Review 10.  Loop Diuretics in Clinical Practice.

Authors:  Se Won Oh; Sang Youb Han
Journal:  Electrolyte Blood Press       Date:  2015-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.